Matthew T. Sweney
No Rating Available
(Learn About Our Rating System)

Matthew T. Sweney, MD, MS

Languages spoken: English

Clinical Locations

Eccles Primary Children's Outpatient Services

Salt Lake City
801-213-3599

Primary Children's Hospital Outpatient Services at Riverton

Riverton
801-213-3599

  • Dr. Sweney is a pediatric neurologist and epileptologist who focuses on the diagnosis and treatment of drug-resistant pediatric epilepsy. He is Medical Director of the Comprehensive Pediatric Epilepsy Program at Primary Children’s Hospital and Program Director of the Pediatric Epilepsy Fellowship at the University of Utah. He is board certified in General Pediatrics, Neurology, Epilepsy, and Clinical Neurophysiology. He participates in all aspects of pediatric epilepsy care, including medication management, non-medication alternatives such as ketogenic diet and neuromodulation, as well as palliative and curative epilepsy surgery. He remains active in ongoing studies into new potential anti-seizure medications and is committed to providing advanced epilepsy care to children of the intermountain region.

    Specialties

    Board Certification

    American Board of Clinical Neurophysiology (Epilepsy Monitoring)
    American Board of Clinical Neurophysiology (Neurophysiologic Intraoperative Monitoring)
    American Board of Pediatrics (Pediatrics)
    American Board of Psychiatry & Neurology (Special Qualification in Child Neurology)
    American Board of Psychiatry & Neurology (Sub: Epilepsy)

  • Dr. Sweney is a pediatric neurologist and epileptologist who focuses on the diagnosis and treatment of drug-resistant pediatric epilepsy. He is Medical Director of the Comprehensive Pediatric Epilepsy Program at Primary Children’s Hospital and Program Director of the Pediatric Epilepsy Fellowship at the University of Utah. He is board certified in General Pediatrics, Neurology, Epilepsy, and Clinical Neurophysiology. He participates in all aspects of pediatric epilepsy care, including medication management, non-medication alternatives such as ketogenic diet and neuromodulation, as well as palliative and curative epilepsy surgery. He remains active in ongoing studies into new potential anti-seizure medications and is committed to providing advanced epilepsy care to children of the intermountain region.

    Board Certification and Academic Information

    Academic Departments Pediatrics -Primary
    Neurology -Primary
    Academic Divisions Neurology
    Board Certification
    American Board of Clinical Neurophysiology (Epilepsy Monitoring)
    American Board of Clinical Neurophysiology (Neurophysiologic Intraoperative Monitoring)
    American Board of Pediatrics (Pediatrics)
    American Board of Psychiatry & Neurology (Special Qualification in Child Neurology)
    American Board of Psychiatry & Neurology (Sub: Epilepsy)

    Education history

    Fellowship Clinical Neurophysiology/Epilepsy - University of Utah Fellow
    General Child Neurology - University of Utah Fellow
    Research Fellow Alternating Hemiplegia of Childhood - University of Utah Research Fellow
    Pediatrics - University of Nebraska - Omaha Resident
    Internship Pediatrics - University of Nebraska - Omaha Intern
    Medicine - University of Nebraska - Omaha M.D.
    Graduate Training Biomedical Engineering - University of Minnesota M.S.
    Bioengineering - University of Nebraska - Lincoln B.S.

    Selected Publications

    Journal Article

    1. Lado FA, Ahrens SM, Riker E, Muh CR, Richardson RM, Gray J, Small B, Lewis SZ, Schofield TJ, Clarke DF, Hopp JL, Lee RR, Salpekar JA, Arnold ST, National Association of Epilepsy Guidelines for Specialized Epilepsy Centers Panel (2024). Guidelines for Specialized Epilepsy Centers: Executive Summary of the Report of the National Association of Epilepsy Centers Guideline Panel. Neurology, 102(4), e208087. (Read full article)
    2. McKnight D, Morales A, Hatchell KE, Bristow SL, Bonkowsky JL, Perry MS, Berg AT, Borlot F, Esplin ED, Moretz C, Angione K, Ros-Pohl L, Nussbaum RL, Aradhya S, ELEVIATE Consortium, Haldeman-Englert CR, Levy RJ, Parachuri VG, Lay-Son G, de Montellano DJD, Ramirez-Garcia MA, Bentez Alonso EO, Ziobro J, Chirita-Emandi A, Felix TM, Kulasa-Luke D, Megarbane A, Karkare S, Chagnon SL, Humberson JB, Assaf MJ, Silva S, Zarroli K, Boyarchuk O, Nelson GR, Palmquist R, Hammond KC, Hwang ST, Boutlier SB, Nolan M, Batley KY, Chavda D, Reyes-Silva CA, Miroshnikov O, Zuccarelli B, Amlie-Wolf L, Wheless JW, Seinfeld S, Kanhangad M, Freeman JL, Monroy-Santoyo S, Rodriguez-Vazquez N, Ryan MM, Machie M, Guerra P, Hassan MJ, Candee MS, Bupp CP, Park KL, Muller E 2nd, Lupo P, Pedersen RC, Arain AM, Murphy A, Schatz K, Mu W, Kalika PM, Plaza L, Kellogg MA, Lora EG, Carson RP, Svystilnyk V, Venegas V, Luke RR, Jiang H, Stetsenko T, Dueas-Roque MM, Trasmonte J, Burke RJ, Hurst ACE, Smith DM, Massingham LJ, Pisani L, Costin CE, Ostrander B, Filloux FM, Ananth AL, Mohamed IS, Nechai A, Dao JM, Fahey MC, Aliu E, Falchek S, Press CA, Treat L, Eschbach K, Starks A, Kammeyer R, Bear JJ, Jacobson M, Chernuha V, Meibos B, Wong K, Sweney MT, Espinoza AC, Van Orman CB, Weinstock A, Kumar A, Soler-Alfonso C, Nolan DA, Raza M, Rojas Carrion MD, Chari G, Marsh ED, Shiloh-Malawsky Y, Parikh S, Gonzalez-Giraldo E, Fulton S, Sogawa Y, Burns K, Malets M, Montiel Blanco JD, Habela CW, Wilson CA, Guzmn GG, Pavliuk M (2022). Genetic Testing to Inform Epilepsy Treatment Management From an International Study of Clinical Practice. JAMA Neurol, 79(12), 1267-1276. (Read full article)
    3. Baker M, Olsen JC, Wilkes J, Sweney M, Soisson S, Bonkowsky JL (2022). Similar antiseizure medication refill characteristics in Hispanic and White pediatric patients. Epilepsy Res, 184, 106970. (Read full article)
    4. Hunsaker JC, Scoville JP, Joyce E, Harper J, Kurudza E, Sweney M, Bollo RJ, Rolston JD (2022). Stereotactic electroencephalography is associated with reduced opioid and nonsteroidal anti-inflammatory drug use when compared with subdural grids: a pediatric case series. J Clin Neurosci, 101, 180-185. (Read full article)
    5. Baker M, Mason CC, Wilkes J, Sant D, Sweney M, Bonkowsky JL (2022). Long-Term Health Outcomes of Infantile Spasms Following Prednisolone vs. Adrenocorticotropic Hormone Treatment Characterized Using Phenome-Wide Association Study. Front Neurol, 13, 878294. (Read full article)
    6. Gregerson CHY, Bakian AV, Wilkes J, Knighton AJ, Nkoy F, Sweney M, Filloux FM, Bonkowsky JL (2019). Disparities in Pediatric Epilepsy Remission Are Associated With Race and Ethnicity. J Child Neurol, 34(14), 928-936. (Read full article)
    7. Afra P, Bruggers CS, Sweney M, Fagatele L, Alavi F, Greenwald M, Huntsman M, Nguyen K, Jones JK, Shantz D, Bulaj G (2018). Mobile Software as a Medical Device (SaMD) for the Treatment of Epilepsy: Development of Digital Therapeutics Comprising Behavioral and Music-Based Interventions for Neurological Disorders. Front Hum Neurosci, 12, 171. (Read full article)

    Other

    1. Viollet L, Glusman G, Murphy KJ, Newcomb TM, Reyna SP, Sweney M, Nelson B, Andermann F, Andermann E, Acsadi G, Barbano RL, Brown C, Brunkow ME, Chugani HT, Cheyette SR, Collins A, DeBrosse SD, Galas D, Friedman J, Hood L, Huff C, Jorde LB, King MD, LaSalle B, Leventer RJ, Lewelt AJ, Massart MB, Mrida MR 2nd, Ptek LJ, Roach JC, Rust RS, Renault F, Sanger TD, Sotero de Menezes MA, Tennyson R, Uldall P, Zhang Y, Zupanc M, Xin W, Silver K, Swoboda KJ (2015). Correction: Alternating Hemiplegia of Childhood: Retrospective Genetic Study and Genotype-Phenotype Correlations in 187 Subjects from the US AHCF Registry. PLoS One (10(8), pp. e0137370). United States. (Read full article)

  • News & Podcasts

    Podcasts

  • Clinical Trials